Canada markets close in 2 hours 36 minutes

Iterum Therapeutics plc (ITRM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.5400-0.0400 (-2.53%)
As of 12:40PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 25.79M
Enterprise Value 20.82M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)6.03
Enterprise Value/Revenue 105.22
Enterprise Value/EBITDA -0.60

Trading Information

Stock Price History

Beta (5Y Monthly) 2.36
52-Week Change 358.00%
S&P500 52-Week Change 325.01%
52 Week High 32.5000
52 Week Low 30.6220
50-Day Moving Average 31.5125
200-Day Moving Average 31.2984

Share Statistics

Avg Vol (3 month) 3625.77k
Avg Vol (10 day) 395.99k
Shares Outstanding 516.43M
Implied Shares Outstanding 616.43M
Float 815.34M
% Held by Insiders 11.52%
% Held by Institutions 17.56%
Shares Short (Mar 28, 2024) 41.23M
Short Ratio (Mar 28, 2024) 46.26
Short % of Float (Mar 28, 2024) 47.60%
Short % of Shares Outstanding (Mar 28, 2024) 47.46%
Shares Short (prior month Feb 29, 2024) 4975.31k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Aug 18, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-63.74%
Return on Equity (ttm)-355.35%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -45.72M
Net Income Avi to Common (ttm)-38.37M
Diluted EPS (ttm)-2.9600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.93M
Total Cash Per Share (mrq)1.46
Total Debt (mrq)19.51M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.89
Book Value Per Share (mrq)-0.47

Cash Flow Statement

Operating Cash Flow (ttm)-39.33M
Levered Free Cash Flow (ttm)-22.38M